Assurance Infusion recalls TRIMIX SUPER (A) 30MG/2MG/30MCG/ML vials due to lack of sterility assurance. Affected lots expired by March 2020.
Lack of sterility assurance.
Assurance Infusion is recalling TRIMIX SUPER (A) 30MG/2MG/30MCG/ML vials because they may not be sterile. This could lead to infections if used improperly.
The vials lack sterility assurance, meaning they could contain harmful bacteria. If injected, this might cause serious infections or other health issues.
Patients using TRIMIX SUPER (A) 30MG/2MG/30MCG/ML vials for medical infusion. Those with specific lot numbers are most at risk.
Check for vial lot numbers: 10152019, 10302019, 08052019, or 10032019. These vials expired by March 2020.
Look for lot numbers on the vial: 10152019, 10302019, 08052019, or 10032019.
The vials lack sterility assurance, which could lead to infections if used.
Lots: 10152019, 10302019, 08052019, 10032019.
Check the vial lot number; affected lots expired by March 2020.
We’ve drafted a message you can send Assurance Infusion to request your refund or repair — edit it as you like.
Subject: Recall D-0779-2020 — Assurance Infusion Assurance Infusion Hello, I own a Assurance Infusion that is covered by recall D-0779-2020 from Assurance Infusion. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
